Chronic Convection Enhanced Delivery of Topotecan
NCT: NCT03154996 · COMPLETED
Brief Summary
The primary goal of this study is to establish, for the first time, safety of prolonged intracerebral convection enhanced delivery of chemotherapy in patients with recurrent high grade glioma (HGG). Secondary objectives will include determination of topotecan (TPT) distribution and radiographic tumor response with prolonged continuous intracerebral convection-enhanced delivery (CED).
Frequently Asked Questions
What is Chronic Convection Enhanced Delivery of Topotecan?
Chronic Convection Enhanced Delivery of Topotecan is a clinical trial registered under NCT03154996. Current status: COMPLETED.
What is the status of NCT03154996?
The current status of NCT03154996 (Chronic Convection Enhanced Delivery of Topotecan) is: COMPLETED.
When did Chronic Convection Enhanced Delivery of Topotecan start?
Chronic Convection Enhanced Delivery of Topotecan started on 2018-01-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.